BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026
BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Brain
CorTec’s Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind
The same fully implanted, wireless device supporting motor recovery after stroke now enables thought-controlled computer use without additional surgery or...
Tru2u.health Expands Digital Health Platform with the Addition of NAD+ – The Cellular Energy Molecule Transforming Modern Wellness
Lake Oswego, Oregon--(Newsfile Corp. - April 29, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and...
Aligning Science Across Parkinson’s and The Michael J. Fox Foundation Expand Global Research Initiative with $261M Investment Toward Personalized Treatments
New funding for 32 international teams aims to unravel the complexity of Parkinson's disease and lay the groundwork for precision...
Medtronic announces CE Mark for Stealth AXiS™ surgical system
Following recent FDA clearances, Medtronic is accelerating access to integrated planning, navigation, and robotics platform across EuropeGALWAY, Ireland, April 28,...
Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) -- Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing...
Trump Psychedelic Executive Order Accelerates Industry Growth
Hypha Labs, Inc. (FUNI) Positioned to Lead with AI-Driven Production Technology LAS VEGAS, NV / ACCESS Newswire / April 27,...
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26, on May 7, 2026
CARSON CITY, Nev., April 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Phase 2 studies ongoing to advance global development of vebreltinib, a highly potent, de-risked and differentiated c-MET Inhibitor with best-in-class...
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
Definitive Agreement Targeted for Execution by June 2026TORONTO, April 27, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB:...
Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work
A 2026 overview of Performance Lab supplements including Mind Lab Pro®, NutriGenesis® Multi, Omega-3, Sleep, Energy, and Vision — covering...
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
BETHESDA, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Neura Health to Expand Access to Migraine Care via LillyDirect
The virtual neurology clinic also offers comprehensive specialty care for epilepsy, chronic pain, concussion, memory conditions, and more; appointments are...
Manatee Appoints Dr. Neha Chaudhary, Harvard Child Psychiatrist and Pioneer in Digital Mental Health, to Board of Directors
DENVER, CO / ACCESS Newswire / April 23, 2026 / Manatee, a virtual provider of structured, whole-family mental health care,...
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models – Data Presented at AACR 2026
Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of Annamycin into a major unmet-need indication...
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
Third patient successfully implanted at Harborview Medical Center as NIH-funded stroke trial advancesFreiburg, Germany, April 23, 2026 (GLOBE NEWSWIRE) --...
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing...
Radiopharm Theranostics Reports Business Update
Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier...
Restart Life Sciences’ Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...
Restart Life Sciences’ Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...